Correction of the anemia of end-stage renal disease with recombinant human erythropoietin: Results of a combined phase I and II clinical trial
Eschbach JW, Egrie JC, Downing MR, Browne JK, Adamson JW. Correction of the anemia of end-stage renal disease with recombinant human erythropoietin: results of a combined phase I and II clinical trial. N Engl J Med 1987;316:73-78
Normalization of hemoglobin level in patients with chronic kidney disease and anemia
DOI 10.1056/NEJMoa062276
Drüeke TB, Locatelli F, Clyne N, et al. Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med 2006;355:2071-2084 (Pubitemid 44749316)
Correction of anemia with epoetin alfa in chronic kidney disease
DOI 10.1056/NEJMoa065485
Singh AK, Szczech L, Tang KL, et al. Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med 2006;355:2085-2098 (Pubitemid 44749317)
Erythropoietin therapy, hemoglobin targets, and quality of life in healthy hemodialysis patients: A randomized trial
Foley RN, Curtis BM, Parfrey PS. Erythropoietin therapy, hemoglobin targets, and quality of life in healthy hemodialysis patients: a randomized trial. Clin J Am Soc Nephrol 2009;4:726-733